USANA HEALTH SCIENCES, INC. Inventory Write-down
USANA HEALTH SCIENCES, INC. (USNA) reported Inventory Write-down of $3.07 million for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. inventory write-down for the quarter ending 2026-07-04 was $1.77M, a 112.23% increase year-over-year.
- USANA HEALTH SCIENCES, INC. inventory write-down for the quarter ending 2026-04-04 was $1.30M, a 7.27% increase year-over-year.
- USANA HEALTH SCIENCES, INC. inventory write-down for the quarter ending 2026-01-03 was $264.00K, a 13100.00% increase year-over-year.
- USANA HEALTH SCIENCES, INC. inventory write-down for the quarter ending 2025-09-27 was $370.00K, a 1.86% decline year-over-year.
- USANA HEALTH SCIENCES, INC. inventory write-down for fiscal 2026 was $2.68M, a 41.67% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. inventory write-down for fiscal 2024 was $1.89M, a 27.30% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. inventory write-down for fiscal 2023 was $2.60M, a 57.23% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. inventory write-down for fiscal 2022 was $6.08M, a 44.81% increase from fiscal 2022.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-07-04 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.07M 10-Q · filed 2026-08-13 | $3.33M derived: sum of 3 quarters · filed 2026-08-13 | $3.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $1.30M 10-Q · filed 2026-05-12 | $1.56M derived: sum of 2 quarters · filed 2026-05-12 | $1.93M derived: sum of 3 quarters · filed 2026-05-12 | $2.77M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $634.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.47M derived: sum of 3 quarters · filed 2026-08-13 | $2.68M 10-K · filed 2026-03-16 |
| 2025-09-27 | $370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.20M derived: sum of 2 quarters · filed 2026-08-13 | $2.42M 10-Q · filed 2025-11-05 | $2.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $834.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.04M 10-Q · filed 2026-08-13 | $2.05M derived: sum of 3 quarters · filed 2026-08-13 | $2.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $1.21M 10-Q · filed 2026-05-12 | $1.21M derived: sum of 2 quarters · filed 2026-05-12 | $1.59M derived: sum of 3 quarters · filed 2026-05-12 | $2.17M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $379.00K derived: sum of 2 quarters · filed 2026-03-16 | $957.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.89M 10-K · filed 2026-03-16 |
| 2024-09-28 | $377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $955.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.89M 10-Q · filed 2025-11-05 | $1.38M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $578.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.51M 10-Q · filed 2025-08-05 | $1.01M derived: sum of 3 quarters · filed 2026-03-16 | $1.43M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $934.00K 10-Q · filed 2025-05-06 | $428.00K derived: sum of 2 quarters · filed 2026-03-16 | $851.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.25M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | -$506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$83.00K derived: sum of 2 quarters · filed 2026-03-16 | $317.00K derived: sum of 3 quarters · filed 2026-03-16 | $2.60M 10-K · filed 2026-03-16 |
| 2023-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $823.00K derived: sum of 2 quarters · filed 2024-11-05 | $3.11M 10-Q · filed 2024-11-05 | |
| 2023-07-01 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.68M 10-Q · filed 2024-08-06 | ||
| 2023-04-01 | $2.28M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $6.08M 10-K · filed 2025-03-12 | |||
| 2022-01-01 | $4.20M 10-K · filed 2024-02-27 | |||
| 2011-10-01 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $888.00K 10-Q · filed 2011-11-09 | ||
| 2011-07-02 | $575.00K 10-Q · filed 2011-08-10 | |||
| 2010-10-02 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $989.00K 10-Q · filed 2011-11-09 | ||
| 2010-07-03 | $601.00K 10-Q · filed 2011-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |